In addition, silencing EMX2 has been suggested to aberrantly activate Wnt signaling in lung adenocarcinoma [17], and some EMT markers are downstream targets of Wnt pathway, such as E-cadherin [28]. This evidence concerns the gene CDH1 and lung adenocarcinoma.